Innoviva (INVA) News Today $20.03 +0.19 (+0.96%) Closing price 04:00 PM EasternExtended Trading$20.57 +0.54 (+2.70%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Algert Global LLC Buys Shares of 13,090 Innoviva, Inc. $INVAAugust 28 at 4:21 AM | marketbeat.comNuveen LLC Acquires New Stake in Innoviva, Inc. $INVAAugust 27 at 3:38 AM | marketbeat.comInnoviva to Participate in Upcoming Investor ConferencesAugust 26 at 7:11 AM | mms.businesswire.comPromising Outlook for Theravance Biopharma: Buy Rating Backed by Phase 3 CYPRESS Trial DevelopmentsAugust 26 at 6:10 AM | tipranks.comAlphaQuest LLC Raises Holdings in Innoviva, Inc. $INVAAugust 26 at 5:31 AM | marketbeat.comQuantbot Technologies LP Boosts Holdings in Innoviva, Inc. $INVAAugust 26 at 4:16 AM | marketbeat.comInnoviva (NASDAQ:INVA) Downgraded by Wall Street Zen to "Buy"August 26 at 3:42 AM | marketbeat.comCharles Schwab Investment Management Inc. Sells 17,857 Shares of Innoviva, Inc. $INVAAugust 26 at 3:21 AM | marketbeat.comInnoviva, Inc. $INVA Shares Purchased by Systematic Financial Management LPAugust 25 at 8:58 AM | marketbeat.comTheravance Completes Enrollment in Phase 3 CYPRESS StudyAugust 25 at 6:50 AM | tipranks.comInvesco Ltd. Decreases Stake in Innoviva, Inc. $INVAAugust 25 at 3:30 AM | marketbeat.comInnoviva (NASDAQ:INVA) Lowered to Buy Rating by Wall Street ZenAugust 25 at 2:39 AM | americanbankingnews.comAmerican Century Companies Inc. Boosts Stake in Innoviva, Inc. $INVAAugust 24, 2025 | marketbeat.comInnoviva, Inc. $INVA Holdings Reduced by Russell Investments Group Ltd.August 24, 2025 | marketbeat.comVanguard Group Inc. Sells 14,018 Shares of Innoviva, Inc. $INVAAugust 24, 2025 | marketbeat.comPublic Sector Pension Investment Board Has $3.17 Million Holdings in Innoviva, Inc. $INVAAugust 21, 2025 | marketbeat.comQSV Equity Investors LLC Sells 33,346 Shares of Innoviva, Inc. $INVAAugust 20, 2025 | marketbeat.comBoston Partners Increases Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)August 18, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Stock Rating Upgraded by Wall Street ZenAugust 18, 2025 | americanbankingnews.comInnoviva (NASDAQ:INVA) Upgraded to Strong-Buy at Wall Street ZenAugust 17, 2025 | marketbeat.comFY2025 EPS Estimates for Innoviva Boosted by HC WainwrightAugust 16, 2025 | marketbeat.comDeutsche Bank AG Trims Stock Position in Innoviva, Inc. (NASDAQ:INVA)August 16, 2025 | marketbeat.comThere May Be Some Bright Spots In Innoviva's (NASDAQ:INVA) EarningsAugust 14, 2025 | uk.finance.yahoo.comResearch Analysts Set Expectations for Innoviva Q3 EarningsAugust 14, 2025 | marketbeat.comAigen Investment Management LP Takes $740,000 Position in Innoviva, Inc. (NASDAQ:INVA)August 13, 2025 | marketbeat.comTheravance Biopharma Inc (TBPH) Q2 2025 Earnings Call Highlights: Strong Sales and Strategic ...August 13, 2025 | gurufocus.comQ2 2025 Theravance Biopharma Inc Earnings Call TranscriptAugust 12, 2025 | gurufocus.comOppenheimer Initiates Coverage of Innoviva (INVA) with Outperform RecommendationAugust 12, 2025 | msn.comInnoviva (NASDAQ:INVA) Trading Up 8.2% After Analyst UpgradeAugust 12, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Innoviva (NASDAQ:INVA) StockAugust 12, 2025 | marketbeat.comOppenheimer Initiates Coverage on Innoviva (NASDAQ:INVA)August 12, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Jefferies Financial Group Inc.August 10, 2025 | marketbeat.comInnoviva, Inc. Just Beat EPS By 54%: Here's What Analysts Think Will Happen NextAugust 9, 2025 | finance.yahoo.comInnoviva (NASDAQ:INVA) Announces Quarterly Earnings ResultsAugust 9, 2025 | marketbeat.comInnoviva FY2026 EPS Estimate Lowered by Cantor FitzgeraldAugust 9, 2025 | marketbeat.comInnoviva (INVA) Q2 Sales Jump 64%August 6, 2025 | fool.comInnoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company ProgressAugust 6, 2025 | businesswire.comGSA Capital Partners LLP Takes $631,000 Position in Innoviva, Inc. (NASDAQ:INVA)August 4, 2025 | marketbeat.com65,117 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by XTX Topco LtdAugust 3, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $627,000 Investment in Innoviva, Inc. (NASDAQ:INVA)August 3, 2025 | marketbeat.comPacer Advisors Inc. Reduces Holdings in Innoviva, Inc. (NASDAQ:INVA)July 27, 2025 | marketbeat.comVictory Capital Management Inc. Buys 234,898 Shares of Innoviva, Inc. (NASDAQ:INVA)July 26, 2025 | marketbeat.comInnoviva (INVA) Expected to Announce Earnings on WednesdayJuly 23, 2025 | marketbeat.comDenali Advisors LLC Raises Stake in Innoviva, Inc. (NASDAQ:INVA)July 19, 2025 | marketbeat.comQ2 Earnings Estimate for Innoviva Issued By HC WainwrightJuly 16, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Innoviva (INVA) with Buy RecommendationJuly 15, 2025 | msn.comInnoviva (NASDAQ:INVA) Upgraded to "Strong-Buy" at HC WainwrightJuly 15, 2025 | marketbeat.comCantor Fitzgerald Predicts Innoviva FY2026 EarningsJuly 14, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Innoviva (INVA) with Overweight RecommendationJuly 12, 2025 | msn.comInnoviva (NASDAQ:INVA) Coverage Initiated at Cantor FitzgeraldJuly 11, 2025 | marketbeat.com Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼1.271.03▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼164▲INVA Articles Average Week Get the Latest News and Ratings for INVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Innoviva and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Novavax News MannKind News Dynavax Technologies News OPKO Health News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access